# Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

> **NCT00191464** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 320 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** premeal insulin lispro mixtures
- **DRUG:** insulin glargine
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT00191464
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 320 (—)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191464, "Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00191464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*